Archita Kukreja
M.B.A., M.S., Lead Healthcare Research & Data Analyst
Archita has authored reports on hematological indications like beta thalassemia and sickle cell disease, infectious diseases and several niche and rare indications. Prior to joining Clarivate, she was a Manager at Sanofi. She has worked on diverse custom and syndicated research project types in several therapeutic areas and has experience in sales- and epidemiology-based forecasting, demand forecasting, commercial opportunity assessments, and market intelligence. She holds double master’s degrees in business administration (M.B.A) and in Science (M.S.) with specialization in Biotechnology from Amity University, Noida, India and Jamia Millia Islamia University, Delhi, India, respectively.
Latest news
ShanghaiRanking’s Academic Ranking of World Universities 2026 Press Release
The 2026 Academic Ranking of World Universities (ARWU) is released today by ShanghaiRanking Consultancy. Since 2003, ARWU has been presenting the world’s top universities annually based on transparent methodology and…
Clarivate and KYBORA Partner to Help Biopharma Companies Execute Strategic Transaction Outcomes
This collaboration combines the scientific and commercial expertise of Clarivate’s Life Sciences & Healthcare Consulting practice with KYBORA’s global transaction execution capabilities to accelerate life sciences transactions London, U.K., August…
Clarivate Enhances SkyRiver to Help Libraries Share, Reuse and Create Trusted Metadata
Combining community metadata sharing, institutional choice and AI-powered record creation LONDON, UK, August 12, 2026 – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the…